Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
Pilot study results explore an NTproBNP-guided strategy to cardioprotection during chemotherapy in patients with cardiotoxicity risks.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas [Phase 1]
Phase 1 trial evaluating duvelisib in combination with romidepsin or with bortezomib for relapsed/refractory T-cell lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
This completed National Cancer Institute study profiled chromatin-associated proteins in lymphoma samples to characterize the composition an…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update reporting the completion of Phase 1 and Phase 2 studies of FF-10502-01 in patients with advanced solid tumors and lymp…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Agriculture Health Study
The Agriculture Health Study (NCT00352924) remains active but not recruiting, continuing investigation into pesticide exposures and cancer r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T) [Phase 2]
Phase 2 MATCH subprotocol T trial update reports testing vismodegib (GDC-0449) in cancers with SMO or PTCH1 mutations; the study is active b…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on Phase 1/2 evaluation of HX009, a recombinant bifunctional antibody targeting CD47 and PD-1, in patient…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors [Phase 1, Phase 2]
The document reports ongoing Phase 1/2 clinical trials evaluating ponatinib in pediatric patients with recurrent or refractory leukemias, ly…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation [Phase 2]
Phase 2 trial of Inotuzumab ozogamicin combined with chemotherapy in leukemia and lymphoma patients undergoing stem cell transplantation was…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. [Phase 2]
A Phase 2 pilot trial is evaluating whether fecal microbiota transplantation can support lymphoma patients treated with axicabtagene ciloleu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma [Phase 2]
A Phase 2 trial assessing romiplostim to treat chemotherapy-induced low platelet counts in patients with lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L) [Phase 2]
Phase 2 clinical trial update evaluating Ulixertinib (BVD-523) in cancers with targeted genetic alterations under MATCH Subprotocol Z1L; the…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H) [Phase 2]
This clinical trial update reports a Phase 2 MATCH subprotocol (H) testing trametinib and dabrafenib for cancers with BRAF genetic alteratio…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology [NA]
A completed clinical trial examined whether a high-fiber, low-fat diet can prevent recurrent Clostridioides difficile infection in oncology …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy [NA]
A completed clinical trial evaluating exercise prehabilitation in older patients with hematological malignancies preparing for CAR-T cell im…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: CMP-001 for Relapsed and Refractory Lymphoma [Phase 1, Phase 2]
Clinical trial CMP-001 for relapsed and refractory lymphoma (Phase 1/Phase 2) has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2) [Phase 2]
Phase 2 MATCH subprotocol update assessing crizotinib for cancers with MET exon 14 deletions; results have been posted (2026-03-20).
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1) [Phase 2]
A Phase 2 MATCH subprotocol evaluating crizotinib for cancers with MET genetic alterations; results have been posted for this study.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is act…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy [Phase 4]
This Phase 4 trial update evaluates the immunogenicity and potential clinical efficacy of the 20-valent pneumococcal conjugate vaccine (PCV2…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: EHealth Educational Intervention to Improve Self-Management and Coping Behaviors Among Cancer Patients [NA]
A completed clinical trial evaluating an eHealth educational intervention to improve self-management and coping behaviors among cancer patie…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma [Phase 2]
This document reports on a Phase II clinical trial evaluating the combination of glofitamab with polatuzumab-R-CHP for high-risk diffuse lar…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer [Phase 2]
Phase 2 trial evaluating psilocybin-assisted existential therapy (PEARL) for patients with advanced cancers; the study is currently active b…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
This clinical trial update indicates active recruitment for a longitudinal study on sexual and reproductive health in women with breast canc…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors
A completed clinical trial update describing a study intended to address financial hardship among adolescent and young adult cancer survivor…